Developing guidance for a risk-proportionate approach to blinding statisticians within clinical trials: a mixed methods study.

This is the first study to develop a guidance document to enhance the understanding of blinding statisticians and to provide a framework for the decision-making process. The key finding was that the decision to blind statisticians should be based on the benefits and risks associated with a particular trial.